U.S. markets closed

Dynavax Technologies Corporation (DVAX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
14.89+0.45 (+3.12%)
At close: 4:00PM EDT

Dynavax Technologies Corporation

2100 Powell Street
Suite 900
EmeryVille, CA 94608
United States
510 848 5100

IndustryDrug Manufacturers—Specialty & Generic
Full Time Employees245

Key Executives

NameTitlePayExercisedYear Born
Mr. Ryan SpencerCEO & Director859.99kN/A1978
Mr. David F. NovackPres & COO799.2kN/A1962
Mr. Michael S. OstrachAdvisor721.35kN/A1952
Dr. Robert JanssenChief Medical Officer and Sr. VP of Clinical Devel., Medical & Regulatory Affairs725.27kN/A1954
Ms. Kelly MacDonaldSr. VP & CFON/AN/A1984
Mr. Justin BurgessPrincipal Accounting Officer & ControllerN/AN/AN/A
Mr. Jeff P. CoonSr. VP of HR & Admin.N/AN/A1963
Nicole ArndtSr. Mang. of Investor RelationsN/AN/AN/A
Mr. John SlebirSr. VP & Gen. CounselN/AN/AN/A
Ms. Meg SmithVP Sales & OperationsN/AN/AN/A
Amounts are as of December 31, 2020 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufactures and sells CpG 1018, the adjuvant used in HEPLISAV-B. Dynavax Technologies Corporation has a collaboration agreement with Valneva Scotland Limited; agreement with Serum Institute of India Pvt. Ltd.; and sublicense agreement with Merck, Sharp & Dohme Corp. The company was formerly known as Double Helix Corporation and changed its name to Dynavax Technologies Corporation in September 1996. Dynavax Technologies Corporation was incorporated in 1996 and is headquartered in Emeryville, California.

Corporate Governance

Dynavax Technologies Corporation’s ISS Governance QualityScore as of July 1, 2021 is 5. The pillar scores are Audit: 6; Board: 3; Shareholder Rights: 8; Compensation: 5.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.